All Oncology News

The OncLive® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses.

Sugar Fueled Diets

May 21st 2012

Is it helpful to add omega-3 fatty acids to minimize the damage?

UK Advisory Group Reverses Decision on Abiraterone; Drug Expected to Be Funded

May 18th 2012

The prostate cancer drug abiraterone acetate is expected be provided for patients through England's publicly funded healthcare system after NICE reversed its initial recommendation.

Healthcare Spending

May 9th 2012

Japan spends the least on healthcare and the US spends the most--without providing superior care for the money.

Pass the Carrots Please

May 1st 2012

Costs associated with obesity are even higher than originally thought.

Pazopanib Receives FDA Approval for Treatment of Soft Tissue Sarcoma

April 27th 2012

The FDA has approved pazopanib for the treatment of patients with advanced soft tissue sarcoma who have previously received chemotherapy.

Landmark Study Redefines Breast Cancer Into 10 Subtypes

April 25th 2012

Researchers have determined that breast cancer can be classified into 10 different subtypes instead of four subtypes as previously thought.

Nurses Needed for the Nurses' Health Study

April 23rd 2012

Landmark study seeks 100,000 new participants.

Revised View Enhances Provenge OS Data

April 19th 2012

A further analysis of clinical trial data for sipuleucel-T suggests that it may have delivered a greater OS benefit than previously described.

Disclosure, Apology, and an Offer

April 19th 2012

New approach to improve the medical liability system expected to reduce healthcare costs.

Cancer Survivors and Causes of Death

April 9th 2012

About half of cancer survivors die from cancer, but the other half die from other causes

Adjuvant Cetuximab Fails to Improve Survival in Colon Cancer

April 3rd 2012

Patients who received cetuximab in combination with a standard adjuvant therapy treatment for colon cancer did not experience improved survival.

Changes Proposed to the Tobacco Control Act

April 2nd 2012

Proposed changes in the Tobacco Control Act have been posted for public comments.

Supreme Court Asks for Reconsideration on BRCA1 and BRCA2 Patents

March 27th 2012

The US Supreme Court has asked an appellate court to reconsider its decision regarding patents held on two genes.

The Future of the Nursing Workforce

March 27th 2012

Because of the current 'bubble', we'll soon be facing another shortage of RNs.

ODAC Endorses Drug for Rare Leukemia

March 21st 2012

ODAC voted 7-4 (2 abstentions) in support of vincristine sulfate liposomes injection to treat patients with Ph-negative ALL.

ODAC Recommends Pazopanib But Not Ridaforolimus for Sarcoma

March 21st 2012

ODAC has recommended the approval of pazopanib but ruled against the agent ridaforolimus to treat sarcoma.

Drug Interactions Significantly Reduce Targeted Therapy Efficacy

March 16th 2012

The DDIs between Co-Rx medications and targeted OAD is associated with a significant decrease in effectiveness and increased toxicity.

PSA Testing Linked to Reduced Mortality

March 15th 2012

PSA testing was shown to significantly reduce mortality among men, but the test had no effect on all-cause mortality.

Zytiga Study Unblinded Following Positive Interim Analysis

March 9th 2012

A phase III study of abiraterone acetate in chemotherapy-naive patients with mCRPC has been unblinded following a positive interim analysis.

Top 5 Contagion® News Articles for the Week of August 27, 2017

March 6th 2012

Stay up-to-date on the latest infectious disease news by checking out this snapshot of our top 5 articles of the week.

x